Fund comparison · from official SEC filings

FMED vs PRHSX: how much do they overlap?

Fidelity Disruptive Medicine ETF and T. Rowe Price Health Sciences Fund, Inc.
Holdings overlap
27%
of assets, by weight
Shared positions
41
of 69 / 287 holdings
FMED expense ratio
0.50%
net, per year
PRHSX expense ratio
0.83%
net, per year
Shared holdings
Company
FMED
PRHSX
L
LLYELI LILLY & CO
0.97%
10.14%
T
TMOTHERMO FISHER SCIENTIFIC INC
1.39%
4.07%
I
ISRGINTUITIVE SURGICAL INC
2.65%
3.65%
S
SYKSTRYKER CORP
1.24%
3.46%
D
DHRDANAHER CORP
3.10%
2.05%
U
UNHUNITEDHEALTH GROUP INC
2.04%
3.09%
A
ARGXARGENX SE - ADR
2.53%
2.92%
C
COGTCOGENT BIOSCIENCES INC
2.59%
0.12%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.53%
1.62%
E
EWEDWARDS LIFESCIENCES CORP
1.91%
0.41%
M
MRNAMODERNA INC
1.91%
0.25%
K
KYMRKYMERA THERAPEUTICS INC
1.80%
0.77%
I
INSMINSMED INC
1.63%
1.06%
P
PCVXVAXCYTE INC
1.60%
0.17%
R
RVMDREVOLUTION MEDICINES INC
1.57%
1.36%
C
CAICARIS LIFE SCIENCES INC
1.55%
0.31%
C
CRNXCRINETICS PHARMACEUTICALS IN
1.49%
0.37%
A
AXSMAXSOME THERAPEUTICS INC
1.43%
0.25%
C
CYTKCYTOKINETICS INC
1.40%
0.40%
B
BTSGBRIGHTSPRING HEALTH SERVICES
1.39%
0.98%
B
BSXBOSTON SCIENTIFIC CORP
1.30%
0.92%
N
NTRANATERA INC
1.29%
1.03%
G
GHGUARDANT HEALTH INC
1.26%
0.90%
V
VRDNVIRIDIAN THERAPEUTICS INC
1.21%
0.06%
A
ALHCALIGNMENT HEALTHCARE INC
1.13%
0.24%
Only in FMED
?
Fidelity Revere Street Trust
9.57%
U
UCBJFUCB SA
4.29%
L
LFSTLIFESTANCE HEALTH GROUP INC
3.87%
T
TXG10X GENOMICS INC-CLASS A
2.82%
L
LEGNLEGEND BIOTECH CORP-ADR
2.08%
T
TECHBIO-TECHNE CORP
2.03%
A
ASNDASCENDIS PHARMA A/S
1.92%
X
XENEXENON PHARMACEUTICALS INC
1.74%
H
HTFLHEARTFLOW INC
1.71%
S
SDMHFSARTORIUS STEDIM BIOTECH
1.67%
V
VEEVVEEVA SYSTEMS INC-CLASS A
1.62%
V
VCYTVERACYTE INC
1.40%
P
PRVAPRIVIA HEALTH GROUP INC
1.34%
K
KNSAKINIKSA PHARMACEUTICALS INTE
1.28%
L
LZAGFLONZA GROUP AG-REG
1.11%
?
Nuvalent Inc
1.10%
D
DXCMDEXCOM INC
1.07%
P
PODDINSULET CORP
1.00%
C
CTMXCYTOMX THERAPEUTICS INC
0.89%
W
WAYWAYSTAR HOLDING CORP
0.89%
I
IRTCIRHYTHM HOLDINGS INC
0.87%
N
NAMSNEWAMSTERDAM PHARMA CO NV
0.83%
A
AMLXAMYLYX PHARMACEUTICALS INC
0.75%
A
ALGNALIGN TECHNOLOGY INC
0.72%
U
UPBUPSTREAM BIO INC
0.46%
Only in PRHSX
M
MRKMERCK & CO. INC.
3.44%
A
AZNASTRAZENECA PLC
3.17%
A
ABBVABBVIE INC
2.84%
R
REGNREGENERON PHARMACEUTICALS
2.65%
G
GILDGILEAD SCIENCES INC
2.60%
J
JNJJOHNSON & JOHNSON
2.44%
V
VRTXVERTEX PHARMACEUTICALS INC
2.43%
?
ASCENDIS PHARMA A/S - ADR
1.42%
U
UTHRUNITED THERAPEUTICS CORP
1.34%
B
BEIGFBEONE MEDICINES LTD-H
1.19%
P
PTGXPROTAGONIST THERAPEUTICS INC
1.11%
S
SMMTSUMMIT THERAPEUTICS INC
1.04%
T
THCTENET HEALTHCARE CORP
1.01%
A
AMGNAMGEN INC
0.98%
H
HCAHCA HEALTHCARE INC
0.90%
C
CVSCVS HEALTH CORP
0.86%
C
CITHE CIGNA GROUP
0.74%
C
CGONCG ONCOLOGY INC
0.69%
C
CAHCARDINAL HEALTH INC
0.68%
E
ELVELEVANCE HEALTH INC
0.66%
K
KRYSKRYSTAL BIOTECH INC
0.65%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.62%
I
IONSIONIS PHARMACEUTICALS INC
0.61%
B
BBIOBRIDGEBIO PHARMA INC
0.59%
C
CHGCFCHUGAI PHARMACEUTICAL CO LTD
0.58%
Hold FMED and PRHSX together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.